This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Methotrexate Injection, USP (2015-03-10)
- Starting date:
- March 10, 2015
- Posting date:
- March 16, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-52531
Recalled Product
Methotrexate Injection, USP
Reason
Visual inspection of retained samples of this lot has revealed presence of particluate matter.
Depth of distribution
Wholesalers and pharmacies
Affected products
Methotrexate Injection, USP
DIN, NPN, DIN-HIM
DIN 02417626
Dosage form
Solution
Strength
Methotrexate (Methotrexate sodium) 50 mg / 2 mL
Lot or serial number
7801370
Companies
- Recalling Firm
-
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA
- Marketing Authorization Holder
-
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA
Related AWRs
